Altimmune
Late clinical-stage biotech working to improve the lives of those living with serious liver diseases
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at Altimmune. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 89 people
- Headquarters
- Gaithersburg, Maryland
- Founded
- 1997
- Type
- Public Company
- Total funding
- $366.4M
Altimmune is a late clinical-stage biopharmaceutical company developing therapies to improve the lives of people living with serious liver diseases. Our lead program is a differentiated dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio, currently in development for metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). #ClinicalResearch #LiverCare #BioResearch